Price $8.06 |
Market Cap
173.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.23
|
P/S
12.79
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-49.6K
|
FCF
-2.2
|
|
Op. Margin
-412.70%
|
Net Margin
-397.70%
|
ROE
-43.20%
|
ROI
-39.60%
|
|
ROA
-37.30%
|
EPS Growth
77.80%
|
Current Ratio
9.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Beyondspring Inc (BYSI) | $1.30 | - | - | 45.6M | Strong Buy |
| Taysha Gene Therapies Inc (TSHA) | $0.79 | - | - | 46M | Strong Buy |
| Psychemedics Corp. (PMD) | $4.75 | - | 5.30% | 30.8M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $2.26 | - | - | 63.1M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.26 | - | - | 14.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
